1) Poorly water-soluble drug
难溶药物
1.
The improvement of poorly water-soluble drug solubility through electrospun drug-loaded nanofibers
电纺载药纳米纤维改善难溶药物溶解性能研究
2) insoluble drug
难溶性药物
1.
Combined effect of cosolvent and cyclodextrin on solubilization of insoluble drugs;
潜溶剂和环糊精对难溶性药物的联合增溶作用
2.
Nanosuspensions can increase the solubility of insoluble drugs, change the pharmacokinetics and improve safety and efficacy.
纳米混悬剂可增大难溶性药物的溶解度,改变药物的体内动力学特征,提高安全性和有效性。
3.
OBJECTIVE To study the effect of ionic strength on insoluble drug release from HPMC hydrogel matrix.
目的 :探讨溶出介质的离子强度对难溶性药物的丙基甲基纤维素 (HPMC)骨架片释药的影响。
3) Poorly water-soluble drug
难溶性药物
1.
This article reviews the study on the delivery system of osmotically Release-controlled and poorly water-soluble drugs from the following four aspects: the thickness and the mechanical permeability of the membrane, the differences of the osmotic pressure and the solubility of Chinese drugs.
本文从膜厚度、膜的的机械穿透系数、包衣膜内外的渗透压差和药物溶解度四个方面,将难溶性药物制备渗透泵型控释制剂的研究进行了归纳总结。
2.
OBJECTIVE To enhance the soluble ability of the poorly water-soluble drug by acid-alkali reaction and prepare monolithic osmotic pump tablet using atenolol as model drug.
目的以阿替洛尔为模型药物,通过酸碱反应提高难溶性药物的溶解能力并制备单层芯渗透泵片。
3.
β-cyclodextrin (βCD) is widely used to improve the solubility of poorly water-soluble drugs.
目前临床上使用的药物当中,有1/3以上为难溶性药物。
4) Poorly soluble drugs
难溶性药物
1.
Solid lipid nanoparticles is a new drug delivery system, which can enhance the bioavailability of poorly soluble drugs.
固体脂质纳米粒作为一种新型给药系统,可以提高难溶性药物生物利用度。
5) water-insoluble drugs
难溶性药物
1.
Objective To introduce the research progress of hydroxypropyl-β-cyclodextrin(HP-β-CD)solubilizing water-insoluble drugs.
目的介绍羟丙基-β-环糊精增溶难溶性药物的研究进展。
补充资料：难溶性磷肥
分子式：
分子量：
CAS号：
性质：见磷肥。
分子量：
CAS号：
性质：见磷肥。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条